The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer

S. Harrow; G. G. Hanna; C. Faivre-Finn; F. McDonald; A. J. Chalmers

doi:10.1016/j.clon.2016.08.004

The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer

S. Harrow^*, G. G. Hanna, C. Faivre-Finn, F. McDonald, A. J. Chalmers

^*Corresponding author for this work

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Article › peer-review

66 Downloads (Pure)

Abstract

Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.

Original language	English
Pages (from-to)	720-725
Number of pages	6
Journal	Clinical Oncology
Volume	28
Issue number	11
Early online date	31 Aug 2016
DOIs	https://doi.org/10.1016/j.clon.2016.08.004
Publication status	Published - 1 Nov 2016

Keywords

DNA damage repair
immunotherapy
NSCLC
radiotherapy
umbrella study

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.clon.2016.08.004

Harrow et al Manuscript Revision Pre-Print for PUREAccepted author manuscript, 198 KB

Cite this

@article{2e1b90090305401a926edc0c5a8db33d,

title = "The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer",

abstract = "Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.",

keywords = "DNA damage repair, immunotherapy, NSCLC, radiotherapy, umbrella study",

author = "S. Harrow and Hanna, {G. G.} and C. Faivre-Finn and F. McDonald and Chalmers, {A. J.}",

year = "2016",

month = nov,

day = "1",

doi = "10.1016/j.clon.2016.08.004",

language = "English",

volume = "28",

pages = "720--725",

journal = "Clinical Oncology",

issn = "0936-6555",

publisher = "Elsevier BV",

number = "11",

}

TY - JOUR

T1 - The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer

AU - Harrow, S.

AU - Hanna, G. G.

AU - Faivre-Finn, C.

AU - McDonald, F.

AU - Chalmers, A. J.

PY - 2016/11/1

Y1 - 2016/11/1

N2 - Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.

AB - Lung cancer is the most common cancer diagnosed in the UK. Outcomes for patients with this disease remain poor and new strategies to treat this disease require investigation. One potential option is to combine novel agents with radiotherapy in clinical studies. Here we discuss some of the important issues to consider when combining novel agents with radiotherapy, together with potential solutions as discussed at a recent Clinical Translational Radiotherapy Group (CTRad) workshop.

KW - DNA damage repair

KW - immunotherapy

KW - NSCLC

KW - radiotherapy

KW - umbrella study

UR - http://www.scopus.com/inward/record.url?scp=84991721367&partnerID=8YFLogxK

U2 - 10.1016/j.clon.2016.08.004

DO - 10.1016/j.clon.2016.08.004

M3 - Article

AN - SCOPUS:84991721367

SN - 0936-6555

VL - 28

SP - 720

EP - 725

JO - Clinical Oncology

JF - Clinical Oncology

IS - 11

ER -

The Challenges Faced in Developing Novel Drug Radiation Combinations in Non-small Cell Lung Cancer

Abstract

Keywords

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this